A case of wet purpura due to etoricoxib induced thrombocytopenia
DOI:
https://doi.org/10.3126/ajms.v7i5.14674Keywords:
Etoricoxib, Drug induced thrombocytopenia, Wet purpuraAbstract
Etoricoxib is a selective cyclo-oxygenase 2 inhibitor, commonly used in treatment of rheumatoid arthritis, gout and back pain. Pretibial edema and erythema, gastric irritation and risks of cardiovascular and cerebrovascular thrombotic events are some of the reported adverse effects due to etoricoxib. This case report is regarding a patient who presented with wet purpura following etoricoxib intake. Drug induced thrombocytopenia is an unreported side effect of etoricoxib.
Asian Journal of Medical Sciences Vol.7(5) 2016 135-137
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).